First, we showed that DLL4 was a potent stimulator of Notch1 signaling mainly in NOTCH1-mutated CLL cells, leading to the activation of some protumor genes and inducing processes that confer aggressiveness to the tumor, such as cell proliferation, migration, and angiogenesis. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.